M&As this week: Advanceleap Corporation, IronRidge Resources, Nebu Resources
Singapore-based Advanceleap Corporation plans to acquire Beijing Raffles Investment Advisory from Sincap Group for SG$10m ($7.21m) under a conditional share sale and purchase agreement.
Also based in Singapore, Sincap Group is involved in alumina and thermal coal trading business, while Beijing Raffles Investment Advisory is a China-based company engaged in mining and sale of gypsum and gypsum-related products in addition to the sale of alumni.
Australia-based IronRidge Resources has agreed to purchase 100% stake in the Chad-based mineral exploration company, Tekton Minerals, for £337.5m ($429.86m).
As part of the transaction, IronRidge will issue ten million shares of its common stock, at a price of £33.75 ($42.98) a share.
IronRidge has engaged SP Angel Corporate Finance and Yellow Jersey as financial advisors for the transaction.
IronRidge Resources is engaged in the discovery and development of iron ore projects.
Nebu Resources plans to acquire the entire issued share capital of Linceo Media Group through a reverse takeover of Nebu by Linceo.
Nebu intends to spin-out its existing mining properties along with settling debts owed to existing creditors, as part of the transaction.
It also intends to issue one new Nebu share for every five issued and outstanding common shares held by its shareholders, as well as adjusting all outstanding options and warrants of Nebu.
Linceo intends to arrange financing through a private placement to complete the transaction.
Nebu Resources is engaged in gold exploration, while Linceo is into mining and exploration of industrial and other minerals.
Both companies involved in the transaction are based in Canada.
Investment company, Zhuhai Special Economic Zone West Sea Group, has announced plans to acquire 50% stake in Billion Hong Mining from Zhongzhu Healthcare Holdings for CNY50.1m ($7.37m).
Billion Hong is a mining company, while Zhongzhu Healthcare Holdings is engaged in the manufacture and marketing of medical equipment and other related products.
All the companies participating in the transaction are based in China.